8 | Acquisition International, Global CFO Excellence Awards 2024 Best Lifecycle Management Healthcare CFO 2024: Mohamed ELRouby tilising a master’s degree in finance and multiple prestigious certifications including, Chartered Global Management Accountant CGMA from UK, FPAC, and CSCA, Mohamed ELRouby’s unrivalled passion for finance has seen him excel in a variety of positions across the different regions since starting his career as a management accountant back in 2003. Highlights of this career in the two decades in major corporations like Johnson & Johnson, Novartis, Energizer and Takeda. This impressive career culminated in Mohamed securing the position of Pharmanovia’s Middle East Africa CFO and Global Commercial Finance Lead, a role he has excelled in now for just shy of three years. With a skillset that includes everything from finance transformation to data analytics and financial consulting, Mohamed has been on the receiving end of industry acclaim during this tenure, even being named as the CFO of the Year for Innovation at the Middle East CFO Vision & Innovation Summit & Awards 2024. Mohamed is also one of the top 25 finance social media influencers in the Arab world and in the top 200 worldwide, boasting an impressive 38.5k followers on LinkedIn. Chartered Global Management Accountant certification is just one of many qualifications that this award-winning CFO holds, and it is his unique knowledge and vast experience in this sector that has helped to take Pharmanovia to new heights. To truly underpin the distinction of Mohamed’s achievements, it pays to explore Pharmanovia and its operation in more detail. From its headquarters in Basildon, a borough in the English county of Essex, global lifecycle management company Pharmanovia pioneers change in this sector by partnering with likeminded pharmaceutical, digital health, and technology distributors and suppliers that share its goals of sustainably and measurably improving the experiences of patients and communities on an international scale. If one was to pick a country at random from the world map, the chances are that Pharmanovia would either have an office there or operate in its market. Collaborating closely with forward-thinking brands and rediscovering, repurposing, and re-engineering their operations and products to drive better outcomes, Pharmanovia has grown considerably over the past decade, expanding its reach from just 15 markets in 2014 to closer to 200 today. This is merely the beginning of its journey, and the team here are constantly scoping out new and exciting corporate partnership opportunities so as to add next-generation medical products to the company’ portfolio that complement its primary areas of focus. The types of partners it is seeking are established brands, innovators in this space, those who offer new dosage forms and technologies, and finally, disruptors of the digital sphere. In return for their partnership, client businesses are afforded access to a leading provider with a robust knowledge that spans everything from corporate development and the commercial market through to the regulatory and technical side of industry. Aside from these corporate partnerships, Pharmanovia also operates across the manufacturing and distribution sectors. From the contract manufacturing organisations it works with for the manufacturing of both its active pharmaceutical ingredients and its packaging, through to the third-party logistics companies, specialist distributors, and contract sales organisations that it uses to market, promote, and distribute these products worldwide, Pharmanovia seeks out the best of the best when it comes to choosing its partners. Forging robust and lasting relationships with those that are capable of delivering on its high standards has proven key to Pharmanovia’s success. Pharmanovia’s unwavering commitment to quality across its operation is reflected further in its product portfolio, which features a range of cardiovascular, endocrinology, neurology, oncology, and miscellaneous pharmaceuticals. This portfolio is growing constantly, with the insights of the company’s patients and clients considered when it comes to Pharmanovia identifying and developing new therapies and treatments, be it through its in-house team or the strategic partnerships that it has a successful track record of building. Thus, at its core, Pharmanovia sees its purpose as being to make medicines today that are fit for tomorrow’s world. By the end of next year, the company anticipates that it will be one of the fastest growing specialist pharmaceutical brands in the world, one that is leading the charge by introducing an effective range of medicines and treatments that target key areas and some of the most common diseases. Committed, agile, and innovative in equal measure, Pharmanovia combines its global reach and local expertise to drive lasting change. It was with more than 20 years of experience thriving as a global finance and strategy lead for some of the world’s leading multinational companies that Mohamed ELRouby came to Pharmanovia in October 2021, securing his position as the company’s CFO for its Middle Eastern and African operations. A global lifecycle management company, Pharmanovia operates in approximately 160 markets worldwide, with more than 15 offices and 300 employees currently to its name. Despite fierce competition, Mohamed is one of the company’s best and brightest. U
RkJQdWJsaXNoZXIy MTUyMDQwMA==